Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
Michel M P J ReijnenIris van WijckThomas ZellerAntonio MicariPierfrancesco VerouxKoen KeirseSeung-Whan LeePei LiDespina VoulgarakiSuzanne HolewijnPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2019)
Treatment of femoropopliteal disease with DCB in CLI patients is safe through 12-month follow-up, with a low major amputation rate of 1.4%. The rates of MAE and CD-TLR were higher in CLI subjects and reinterventions were required sooner. Additional research is needed to evaluate long-term outcomes of DCB treatment for femoropopliteal lesions in CLI patients.